ArticleJournal of gastrointestinal oncology2025

Real-world effectiveness and safety of TACE combined with lenvatinib plus immune checkpoint inhibitors in patients with BCLC-B stage hepatocellular carcinoma.

Yu Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.